Both in Pharmaceuticals
Q32 Bio vs Upstream Bio
Over the past year QTTB returned +391.2% and UPB returned −70.1%; their daily moves had a correlation of 0.08.
QTTB +391.2% UPB −70.1%Growth of $1, one year, split-adjusted
| Metric | QTTB | UPB |
|---|---|---|
| Price | $9.53 | $5.19 |
| Market cap | $283.7M | $284.3M |
| Today | +3.25% | −2.08% |
| 1 month | −36.6% | −22.4% |
| 6 months | +61.5% | −40.9% |
| Year to date | +187.0% | −80.9% |
| 1 year | +404.2% | −69.9% |
| Revenue growth (YoY) | — | −17.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5136.1% |
| P/E (TTM) | 8.4× | — |
| Price / sales | 5.3× | 90.0× |
| Net cash | $106.3M | $261.3M |
| Dividend yield | — | — |
| Volatility (60d) | 153.8% | 55.6% |
| Short % of float | 30.6% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).